Apr 25 |
PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M
|
Apr 25 |
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
Apr 24 |
PTC Therapeutics Q1 2024 Earnings Preview
|
Apr 18 |
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Apr 11 |
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
|
Mar 28 |
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
|
Mar 25 |
A Comprehensive Look at Sarepta's Growth and Innovation
|
Mar 21 |
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
|
Mar 20 |
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
|
Mar 19 |
PTC Therapeutics Provides Key Regulatory Updates
|